JP Patent

JP2005521673A — 炎症性およびアレルギー性状態の治療のためのアンドロスタン誘導体の水性懸濁物を含む医薬製剤

Assigned to Glaxo Group Ltd · Expires 2005-07-21 · 21y expired

What this patent protects

式(I)の粒子状化合物またはその溶媒和物の水性懸濁物を含む医薬製剤が提供される。 【化１】

USPTO Abstract

式(I)の粒子状化合物またはその溶媒和物の水性懸濁物を含む医薬製剤が提供される。 【化１】

Drugs covered by this patent

Patent Metadata

Patent number
JP2005521673A
Jurisdiction
JP
Classification
—
Expires
2005-07-21
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.